Kava (Piper methysticum) is a plant root traditionally used for its calming effects. It is commonly sold as a supplement and a beverage (e.g., tea).
In the early 2000’s, a German study found that kava was associated with rare cases of severe liver injury. In response, many countries restricted kava’s use or banned it outright. However, the results of the German study were ultimately contested and regulations regarding kava were relaxed in some jurisdictions. For details, see New York Times, New Questions About Kava’s Safety (Jan. 16, 2002); see also Planta Medica, German Kava Ban Lifted by Court (Dec. 2015).
However, kava remains restricted for sale in several countries, including:
Australia: Kava is a Schedule 4 prescription-only medicine except at specified lower dosages.
Netherlands: Kava is prohibited in herbal preparations.
Singapore: Kava is prohibited in health supplements.
United Kingdom: Kava is prohibited in both medicines and food.
United States: Kava is commonly sold as a dietary supplement. However, it is restricted for sale as a conventional food. See FDA, Warning Letter to Herbal Junction (March 11, 2016) (“Kava kava [is] not approved for use in any conventional food. Therefore, your liquid concentrates, coolers, herbal infusions and bars which contain kava kava […] are adulterated within the meaning of [the Food, Drug, and Cosmetic Act].”).
G2RS has always reported kava as “pVIO-Illegal drugs,” under the sub-category, “May contain illegal.” However, starting next month, we will report kava as “pVIO-Illegal drugs” under its own sub-category, “Kava.” This will allow us to re-report all kava merchants, as well as bring greater visibility to this risk area.
For additional information about kava, please reach out to your Customer Success representative and ask for a copy of G2RS’ guide titled Kava: Regulatory Overview.